GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,246 | -909 | -641 | -286 | -5,006 |
| Depreciation Amortization | 734 | 89 | 36 | 14 | 803 |
| Accounts receivable | N/A | -13 | -10 | N/A | 145 |
| Accounts payable and accrued liabilities | N/A | 69 | 49 | 48 | 252 |
| Other Working Capital | 380 | 343 | 219 | 143 | 561 |
| Other Operating Activity | 195 | 166 | 136 | 49 | 3,076 |
| Operating Cash Flow | $-937 | $-255 | $-211 | $-32 | $-169 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 233 | 233 | 10 | N/A |
| Debt Issued | 2,233 | N/A | N/A | N/A | N/A |
| Debt Repayment | -25 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $2,208 | $233 | $233 | $10 | $N/A |
| Beginning Cash Position | 22 | 22 | 22 | 22 | 191 |
| End Cash Position | 1,293 | N/A | 44 | N/A | 22 |
| Net Cash Flow | $1,271 | $-22 | $22 | $-22 | $-169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -937 | -255 | -211 | -32 | -169 |
| Free Cash Flow | -937 | -255 | -211 | -32 | -169 |